Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol valerate/dienogest versus Microgynon for hormone withdrawal symptoms after 6 treatment cycles
2008-003226-42Phase 3Completed
- Sponsor
- Bayer
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of estradiol valerate, dienogest, ethinylestradiol + levonorgestrel, ethinyl estradiol and avatrombopag in Headache and pelvic pain (2 arms), sponsored by Bayer. Primary endpoints: Primary efficacy endpoint and Primary objective. Started Oct 2008; status: completed.
02
Drugs
estradiol valeratedienogestethinylestradiol + levonorgestrelethinyl estradiolavatrombopag
03
Conditions
Headachepelvic pain
Beyond the preview
Go deeper on 2008-003226-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003226-42.